Dr David Johnson selects his 10 highest-impact publications from 2025, which define new management standards across a broad spectrum of diseases.

A team led by clinicians and engineers has wrapped the plant-derived polyphenol pterostilbene (PSB) into prebiotic ...

A new study published in the Journal of Gastroenterology and Hepatology showed the need for steroid-sparing strategies is ...

Learn about common early signs of ulcerative colitis, including blood in stool, diarrhea, cramping, bloating, and bowel changes, for a prompt diagnosis and effective treatment.

Crohn's disease is a chronic inflammatory bowel disease that requires long-term medical and surgical management to improve quality of life.

Ultra-processed foods can drive higher Crohn’s disease risk, weaken the gut’s protective barrier, and intensify inflammation.

Psychologist Melissa Hunt and gastroenterologist Chung Sang Tse and colleagues have found that cognitive behavioral therapy ...

The ulcerative colitis market is experiencing steady growth driven by rising disease prevalence and increasing diagnosis rates worldwide. Expanding adoption of advanced biologics, small-molecule ...

DelveInsight's Ulcerative Colitis Market Insights report includes a comprehensive understanding of current treatment practices, ulcerative colitis emerging drugs, market share of individual therapies, ...

Ulcerative Colitis Market Summary -- The market size for ulcerative colitis in the leading markets is expected to grow significantly by 2034. -- The United States accounted for the highest ulcerative ...

Ulcerative Colitis Pipeline Insight – 2025 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key ...